Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Filing Date
Global Rank
#6,180
/ 8,232
▼ 3986
Top Industry
Biotechnology
49.2%
3Y Alpha vs SPY
-6.1%
Period ended 2 months ago
Filed May 14, 2026 · 31d
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+15.0%
SPY
+23.4%
Annualised alpha
-6.1%
Max drawdown
−25.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
62 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
14.3%
+0.8 pts
Top 5
34.2%
−19.1 pts
Top 10
53.5%
−26.4 pts
HHI
451
Diversified−334
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 76.7% | $47,965,668 |
| Communication Services | 14.3% | $8,950,880 |
| Technology | 6.9% | $4,286,771 |
| Financial Services | 1.4% | $899,256 |
| Unclassified | 0.4% | $273,142 |
| Basic Materials | 0.2% | $99,748 |
| Real Estate | 0.0% | $28,997 |
| Industrials | 0.0% | $25,330 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
19 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PTCT | Ptc Therapeutics, Inc. | +30,463 | 39,701 | $2,704,829 | |
| GOOGL | Alphabet Inc. | +29,727 | 31,127 | $8,950,880 | |
| PFE | Pfizer Inc | +27,971 | 71,313 | $2,002,469 | |
| NBIX | Neurocrine Biosciences Inc | +18,039 | 21,556 | $2,839,787 | |
| AXSM | Axsome Therapeutics, Inc. | +14,291 | 16,401 | $2,772,097 | |
| IONS | Ionis Pharmaceuticals Inc | +13,971 | 38,988 | $2,927,608 | |
| ASND | Ascendis Pharma A/S | +8,831 | 11,828 | $2,705,418 | |
| COGT | Cogent Biosciences, Inc. | +6,431 | 13,784 | $530,546 | |
| RVMD | Revolution Medicines, Inc. | +4,771 | 7,971 | $775,179 | |
| TWST | Twist Bioscience Corp | +3,484 | 13,476 | $640,379 | |
| BLTE | Belite Bio, Inc | +2,955 | 6,004 | $957,277 | |
| CYTK | Cytokinetics Inc | +2,908 | 7,388 | $486,943 | |
| BBIO | BridgeBio Pharma, Inc. | +2,860 | 5,785 | $429,594 | |
| DYN | Dyne Therapeutics, Inc. | +2,830 | 17,213 | $312,071 | |
| BIIB | Biogen Inc. | +1,851 | 4,706 | $862,750 | |
| PRAX | Praxis Precision Medicines, Inc. | +1,773 | 3,855 | $1,242,042 | |
| REGN | Regeneron Pharmaceuticals, Inc. | +964 | 2,502 | $1,933,145 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | +821 | 1,192 | $623,976 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | +48 | 3,412 | $1,523,594 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
15 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | −306,027 | 7,902 | $1,931,564 | |
| TEVA | Teva Pharmaceutical Industries Ltd | −126,907 | 25,805 | $777,246 | |
| OSG | Octave Specialty Group Inc | −63,843 | 139,168 | $647,131 | |
| GMAB | Genmab A/S | −27,198 | 16,030 | $430,084 | |
| LITE | Lumentum Holdings Inc. | −10,925 | 562 | $394,951 | |
| LLY | ELI LILLY & Co | −8,751 | 442 | $406,538 | |
| SYRE | Spyre Therapeutics, Inc. | −7,584 | 6,140 | $309,701 | |
| GILD | Gilead Sciences, Inc. | −7,458 | 11,961 | $1,667,004 | |
| NVST | Envista Holdings Corp | −5,699 | 9,001 | $228,355 | |
| COO | Cooper Companies, Inc. | −4,538 | 5,896 | $421,564 | |
| INSM | INSMED Inc | −4,538 | 7,018 | $1,147,583 | |
| AXGN | Axogen, Inc. | −2,929 | 16,273 | $539,124 | |
| APGE | Apogee Therapeutics, Inc. | −2,317 | 4,007 | $337,269 | |
| NKTR | Nektar Therapeutics | −2,097 | 2,830 | $203,618 | |
| AMGN | Amgen Inc | −1,025 | 4,934 | $1,736,027 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ASX | ASE Technology Holding Co., Ltd. | 179,512 | $3,891,820 | |
| BMRN | Biomarin Pharmaceutical Inc | 48,719 | $2,752,136 | |
| UNH | Unitedhealth Group Inc | 5,216 | $1,411,397 | |
| PTGX | Protagonist Therapeutics, Inc | 9,334 | $983,803 | |
| MRNA | Moderna, Inc. | 17,097 | $868,527 | |
| BNTX | BioNTech SE | 6,890 | $612,383 | |
| NTRA | Natera, Inc. | 2,970 | $593,970 | |
| TNGX | Tango Therapeutics, Inc. | 20,463 | $428,085 | |
| ERAS | Erasca, Inc. | 24,847 | $402,024 | |
| ILMN | Illumina, Inc. | 3,026 | $372,984 | |
| BIOA | BioAge Labs, Inc. | 20,796 | $363,722 | |
| IBRX | ImmunityBio, Inc. | 41,005 | $314,508 | |
| UTHR | UNITED THERAPEUTICS Corp | 527 | $312,500 | |
| TYRA | Tyra Biosciences, Inc. | 8,075 | $309,272 | |
| SPY | Spdr S&P 500 ETF Trust | 420 | $273,142 | |
| ALMS | Alumis Inc. | 12,031 | $265,042 | |
| ORKA | Oruka Therapeutics, Inc. | 5,147 | $252,460 | |
| EQH | Equitable Holdings, Inc. | 6,794 | $252,125 | |
| SMMT | Summit Therapeutics Inc. | 12,136 | $230,098 | |
| CGON | CG Oncology, Inc. | 3,370 | $228,081 | |
| DXCM | Dexcom Inc | 3,628 | $227,838 | |
| GPCR | Structure Therapeutics Inc. | 4,190 | $201,958 | |
| VSTM | Verastem, Inc. | 36,170 | $191,701 | |
| CLYM | Climb Bio, Inc. | 24,590 | $168,441 | |
| UAMY | United States Antimony Corp | 11,426 | $99,748 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NVDA | Nvidia Corp | 442,100 | $82,451,650 | |
| MSFT | Microsoft Corp | 145,000 | $70,124,900 | |
| C | Citigroup Inc | 464,000 | $54,144,160 | |
| HD | Home Depot, Inc. | 156,840 | $53,968,644 | |
| QCOM | Qualcomm Inc/De | 312,600 | $53,470,230 | |
| PLTR | Palantir Technologies Inc. | 279,000 | $49,592,250 | |
| AMZN | Amazon Com Inc | 88,000 | $20,312,160 | |
| AAPL | Apple Inc. | 72,000 | $19,573,920 | |
| AEG | Aegon Ltd. | 2,527,483 | $19,486,893 | |
| TSLA | Tesla, Inc. | 43,000 | $19,337,960 | |
| PYPL | PayPal Holdings, Inc. | 324,000 | $18,915,120 | |
| MRK | Merck & Co., Inc. | 46,686 | $4,914,168 | |
| RL | Ralph Lauren Corp | 8,796 | $3,110,353 | |
| COHR | Coherent Corp. | 12,818 | $2,365,818 | |
| MRVL | Marvell Technology, Inc. | 27,413 | $2,329,556 | |
| ASTS | AST SpaceMobile, Inc. | 31,523 | $2,289,515 | |
| BIDU | Baidu, Inc. | 15,000 | $1,959,900 | |
| AMKR | Amkor Technology, Inc. | 48,698 | $1,922,597 | |
| ABBV | AbbVie Inc. | 8,038 | $1,836,602 | |
| ATAT | Atour Lifestyle Holdings Ltd | 38,787 | $1,528,207 | |
| SNDK | Sandisk Corp | 5,906 | $1,401,966 | |
| EW | Edwards Lifesciences Corp | 16,364 | $1,395,031 | |
| DHR | Danaher Corp /De/ | 5,368 | $1,228,842 | |
| APH | Amphenol Corp /De/ | 8,900 | $1,202,746 | |
| BZ | Kanzhun Ltd | 56,000 | $1,141,280 | |
| No positions match the current search. | ||||
62 positions ·
$62,529,792 total
· as of Mar 31, 2026
All sectors
Basic Materials
Communication Services
Financial Services
Healthcare
Industrials
Real Estate
Technology
Showing 1–50
of 62 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GOOGL |
Alphabet Inc.
Communication Services
|
Added | 31,127 | $8,950,880 | 14.31% | |
| ASX |
ASE Technology Holding Co., Ltd.
Technology
|
NEW | 179,512 | $3,891,820 | 6.22% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 38,988 | $2,927,608 | 4.68% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Added | 21,556 | $2,839,787 | 4.54% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 16,401 | $2,772,097 | 4.43% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
NEW | 48,719 | $2,752,136 | 4.40% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 11,828 | $2,705,418 | 4.33% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 39,701 | $2,704,829 | 4.33% | |
| PFE |
Pfizer Inc
Healthcare
|
Added | 71,313 | $2,002,469 | 3.20% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Added | 2,502 | $1,933,145 | 3.09% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 7,902 | $1,931,564 | 3.09% | |
| AMGN |
Amgen Inc
Healthcare
|
Reduced | 4,934 | $1,736,027 | 2.78% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Reduced | 11,961 | $1,667,004 | 2.67% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Added | 3,412 | $1,523,594 | 2.44% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 5,216 | $1,411,397 | 2.26% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 3,855 | $1,242,042 | 1.99% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 7,018 | $1,147,583 | 1.84% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
NEW | 9,334 | $983,803 | 1.57% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Added | 6,004 | $957,277 | 1.53% | |
| MRNA |
Moderna, Inc.
Healthcare
|
NEW | 17,097 | $868,527 | 1.39% | |
| BIIB |
Biogen Inc.
Healthcare
|
Added | 4,706 | $862,750 | 1.38% | |
| TEVA |
Teva Pharmaceutical Industries Ltd
Healthcare
|
Reduced | 25,805 | $777,246 | 1.24% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 7,971 | $775,179 | 1.24% | |
| OSG |
Octave Specialty Group Inc
Financial Services
|
Reduced | 139,168 | $647,131 | 1.03% | |
| TWST |
Twist Bioscience Corp
Healthcare
|
Added | 13,476 | $640,379 | 1.02% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 1,192 | $623,976 | 1.00% | |
| BNTX |
BioNTech SE
Healthcare
|
NEW | 6,890 | $612,383 | 0.98% | |
| NTRA |
Natera, Inc.
Healthcare
|
NEW | 2,970 | $593,970 | 0.95% | |
| AXGN |
Axogen, Inc.
Healthcare
|
Reduced | 16,273 | $539,124 | 0.86% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 13,784 | $530,546 | 0.85% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 7,388 | $486,943 | 0.78% | |
| GMAB |
Genmab A/S
Healthcare
|
Reduced | 16,030 | $430,084 | 0.69% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 5,785 | $429,594 | 0.69% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 20,463 | $428,085 | 0.68% | |
| COO |
Cooper Companies, Inc.
Healthcare
|
Reduced | 5,896 | $421,564 | 0.67% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 442 | $406,538 | 0.65% | |
| ERAS |
Erasca, Inc.
Healthcare
|
NEW | 24,847 | $402,024 | 0.64% | |
| LITE |
Lumentum Holdings Inc.
Technology
|
Reduced | 562 | $394,951 | 0.63% | |
| ILMN |
Illumina, Inc.
Healthcare
|
NEW | 3,026 | $372,984 | 0.60% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
NEW | 20,796 | $363,722 | 0.58% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 4,007 | $337,269 | 0.54% | |
| IBRX |
ImmunityBio, Inc.
Healthcare
|
NEW | 41,005 | $314,508 | 0.50% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
NEW | 527 | $312,500 | 0.50% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 17,213 | $312,071 | 0.50% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 6,140 | $309,701 | 0.50% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
NEW | 8,075 | $309,272 | 0.49% | |
| SPY |
Spdr S&P 500 ETF Trust
|
NEW | 420 | $273,142 | 0.44% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 12,031 | $265,042 | 0.42% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 5,147 | $252,460 | 0.40% | |
| EQH |
Equitable Holdings, Inc.
Financial Services
|
NEW | 6,794 | $252,125 | 0.40% |